Bernard-Raichon, Lucie
Venzon, Mericien
Klein, Jon http://orcid.org/0000-0002-3552-7684
Axelrad, Jordan E. http://orcid.org/0000-0003-1951-7790
Zhang, Chenzhen
Sullivan, Alexis P. http://orcid.org/0000-0001-9296-8112
Hussey, Grant A.
Casanovas-Massana, Arnau http://orcid.org/0000-0002-3301-6143
Noval, Maria G.
Valero-Jimenez, Ana M.
Gago, Juan
Putzel, Gregory
Pironti, Alejandro http://orcid.org/0000-0002-7759-6776
Wilder, Evan
Obaid, Abeer
Lu-Culligan, Alice
Nelson, Allison
Brito, Anderson
Nunez, Angela
Martin, Anjelica
Watkins, Annie
Geng, Bertie
Kalinich, Chaney
Harden, Christina
Todeasa, Codruta
Jensen, Cole
Kim, Daniel
McDonald, David
Shepard, Denise
Courchaine, Edward
White, Elizabeth B.
Song, Eric
Silva, Erin
Kudo, Eriko
DeIuliis, Giuseppe
Rahming, Harold
Park, Hong-Jai
Matos, Irene
Nouws, Jessica
Valdez, Jordan
Fauver, Joseph
Lim, Joseph
Rose, Kadi-Ann
Anastasio, Kelly
Brower, Kristina
Glick, Laura
Sharma, Lokesh
Sewanan, Lorenzo
Knaggs, Lynda
Minasyan, Maksym
Batsu, Maria
Petrone, Mary
Kuang, Maxine
Nakahata, Maura
Campbell, Melissa
Linehan, Melissa
Askenase, Michael H.
Simonov, Michael
Smolgovsky, Mikhail
Sonnert, Nicole
Naushad, Nida
Vijayakumar, Pavithra
Martinello, Rick
Datta, Rupak
Handoko, Ryan
Bermejo, Santos
Prophet, Sarah
Bickerton, Sean
Velazquez, Sofia
Alpert, Tara
Rice, Tyler
Khoury-Hanold, William
Peng, Xiaohua
Yang, Yexin
Cao, Yiyun
Strong, Yvette
Thorpe, Lorna E.
Littman, Dan R.
Dittmann, Meike
Stapleford, Kenneth A.
Shopsin, Bo
Torres, Victor J. http://orcid.org/0000-0002-7126-0489
Ko, Albert I. http://orcid.org/0000-0001-9023-2339
Iwasaki, Akiko http://orcid.org/0000-0002-7824-9856
Cadwell, Ken
Schluter, Jonas http://orcid.org/0000-0002-6214-9367
,
Article History
Received: 13 June 2022
Accepted: 12 September 2022
First Online: 1 November 2022
Competing interests
: K.C. has received research support from Pfizer, Takeda, Pacific Biosciences, Genentech, and Abbvie; consulted for or received an honoraria from Puretech Health, Genentech, and Abbvie; and is named as an inventor on U.S. patent 10,722,600 and provisional patents 62/935,035 and 63/157,225. J.S. is cofounder of Postbiotics Plus Research LLC. The remaining authors declare no competing interests.
: The collection of COVID-19 human biospecimens for research has been approved by the NYUSOM Institutional Review Board under il8-01121 Inflammatory Bowel Disease and Enteric Infection at NYU Langone Health. The data presented in this study were also approved by Yale Human Research Protection Program Institutional Review Boards (FWA00002571, protocol ID 2000027690). Informed consent was obtained from all enrolled patients.